[Federal Register Volume 76, Number 228 (Monday, November 28, 2011)]
[Notices]
[Pages 72976-72977]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-30550]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Registration

    By Notice dated June 22, 2011, and published in the Federal 
Register on June 29, 2011, 76 FR 38209, Pharmagra Labs Inc., 158 McLean 
Road, Brevard, North Carolina 28712, made application to the Drug 
Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Pentobarbital (2270), a basic class of controlled 
substance in schedule II.
    The company plans to manufacture the listed controlled substance 
for analytical research and clinical trials.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Pharmagra Labs, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Pharmagra Labs, Inc. to ensure that the

[[Page 72977]]

company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823(a), and in accordance 
with 21 CFR 1301.33, the above named company is granted registration as 
a bulk manufacturer of the basic class of controlled substance listed.

     Dated: November 18, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2011-30550 Filed 11-25-11; 8:45 am]
BILLING CODE 4410-09-P